During thymic T cell development, CD4^+^CD8^+^ double-positive (DP) thymocytes that express functional TCR are subjected to positive or negative selection and mature into CD4 or CD8 single-positive (SP) thymocytes ([@bib26]). Thymic selection also leads to the development of FoxP3^+^ T regulatory (T reg) cells, which play a critical role in maintaining self-tolerance ([@bib6]; [@bib9]; [@bib11]). A major drive for thymic and mature T cell development are signals emanating from the TCR ([@bib21]). PLCγ1 is an essential effector molecule in TCR signal transduction, which, after activation, hydrolyzes the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP~2~) to generate diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP~3~; [@bib20]). Whereas DAG activates the NF-κB and GRP--Ras--ERK pathways ([@bib5]; [@bib14]), IP~3~ mediates the elevation of Ca^2+^, which is essential for NFAT activation ([@bib19]). The capability of PLCγ1 to regulate multiple signaling pathways and transcription factors raises considerable interest in the biological role of PLCγ1. However, embryonic lethality of PLCγ1-deficient mice precludes the analysis to determine the role of PLCγ1 in T cell biology in vivo ([@bib10]). Here, we generate conditional PLCγ1-deficient mice, in which PLCγ1 deficiency is restricted to the T cell lineage. Our results demonstrate that PLCγ1 plays a critical and as yet unknown multifold role in T cell biology.

RESULTS AND DISCUSSION
======================

Generation of PLCγ1-deficient mice
----------------------------------

To avoid embryonic lethality caused by PLCγ1 deficiency, we modified *PLCγ1* locus by "floxing" exons 2--4 of *PLCγ1* ([Fig. S1](http://www.jem.org/cgi/content/full/jem.20090880/DC1)). The offspring that inherited the "floxed" *PLCγ1* (PLCγ1^fl/+^) were bred with PLCγ1^+/−^ mice ([@bib10]). CD4Cre (Cre) transgene was introduced into the PLCγ1^fl/−^ mice to mediate *PLCγ1* deletion at thymic DP stage ([@bib13]). PLCγ1 proteins were absent or substantially reduced in DP and SP thymocytes, and splenic T cells from Cre/PLCγ1^fl/−^ compared with Cre/PLCγ1^+/−^ mice ([Fig. S2 A](http://www.jem.org/cgi/content/full/jem.20090880/DC1)), and truncated PLCγ1 was not generated (not depicted). The residual PLCγ1 proteins in peripheral T cells of Cre/PLCγ1^fl/−^ mice may reflect preferential survival and/or amplification of rare thymocytes that failed to delete the *PLCγ1* gene. To better track deletion of the "floxed" *PLCγ1*, we used Rosa-26-YFP (YFP) mice ([@bib25]). PLCγ1 expression was not observed in YFP^+^ thymocytes and splenic T cells (Fig. S2 B). Thus, YFP expression correlates with Cre-mediated deletion of the floxed *PLCγ1* in T cells.

PLCγ1 deficiency impairs thymocyte maturation
---------------------------------------------

We examined T cell development in Cre/PLCγ1^fl/−^ mice. PLCγ1^+/−^, PLCγ1^fl/−^, and Cre/PLCγ1^+/−^ mice showed normal T cell development compared with WT mice, and thus served as experimental controls ([Table I](#tbl1){ref-type="table"} and not depicted). Total thymocyte number of Cre/PLCγ1^fl/−^ mice was reduced compared with that of the control mice, but not statistically significant ([Table I](#tbl1){ref-type="table"}). Whereas the percentage of DN thymocytes was not significantly changed, the percentage of DP thymocytes was slightly but consistently increased in Cre/PLCγ1^fl/−^ mice relative to controls ([Table I](#tbl1){ref-type="table"}). Moreover, there was a dramatic reduction in the percentages and absolute numbers of SP thymocytes derived from Cre/PLCγ1^fl/−^ mice relative to controls, with CD4SP thymocytes more profoundly affected than CD8SP thymocytes ([Table I](#tbl1){ref-type="table"}). Further analysis showed that the percentage of the "bipotent" CD4^+^CD8^lo^YFP^+^ thymocytes that differentiate into either CD4 or CD8 SP thymocytes was reduced by 55 ± 16% in Cre/YFP/PLCγ1^fl/−^ mice compared with Cre/YFP/PLCγ1^+/−^ mice. The percentage of CD4^+^CD8^−^YFP^+^ thymocytes was further reduced by 82 ± 5% ([Fig. 1 A](#fig1){ref-type="fig"}). Importantly, expression of Th-POK, the transcription factor that determines CD4 T cell commitment ([@bib8]), was significantly lower in CD4^+^CD8^lo^CD69^+^YFP^+^ and CD4^+^CD8^−^CD69^+^YFP^+^ thymocytes from Cre/YFP/PLCγ1^fl/−^ relative to Cre/YFP/PLCγ1^+/−^ mice ([Fig. 1 B](#fig1){ref-type="fig"}). Thus, PLCγ1 deficiency impaired the development of the bipotent CD4^+^CD8^lo^ thymocytes, and further development of both CD4 and CD8 thymocytes. In addition, PLCγ1 deficiency reduced the up-regulation of Th-POK in CD4^+^CD8^lo^ and CD4^+^CD8^−^ thymocytes, providing one possible explanation for the greater affect on the CD4SP population. Finally, compared with Cre/YFP/PLCγ1^+/−^ mice, Cre/YFP/PLCγ1^fl/−^ mice lacked a small population of DP thymocytes that up-regulated CD3 and CD69 ([Fig. 1 C](#fig1){ref-type="fig"}), and had reduced CD5 up-regulation on DP thymocytes and CD3, CD5, and CD69 up-regulation on SP thymocytes ([Fig. 1 C](#fig1){ref-type="fig"}). These data are consistent with the notion that PLCγ1 deficiency reduces TCR signaling.

###### 

Analysis of T cell populations in Cre/PLCγ1^fl/−^ and the control mice

                                             Thymocytes   Splenocytes                                                                                                                                                                                                                                   
  ------------------------------- ---------- ------------ ------------- -------------------------------------------- --------------------------------------------- -------------------------------------------- ------------------------------------------ -------------------------------------------- --------------------------------------------
  **PLCγ1**^+/−^ (*n* = 6)        \%                      1.5 ± 0.8     87 ± 2.8                                     8.5 ± 1.5                                     2.7 ± 1.2                                                                               22 ± 3.6                                     15 ± 2.9
  \# (×10^6^)                     216 ± 76   3.2 ± 2.0    189 ± 69      19 ± 8.3                                     6.4 ± 4.1                                     100 ± 46                                     22 ± 11                                    15 ± 6.6                                     
  **PLCγ1**^fl/−^ (*n* = 6)       \%                      1.1 ± 0.7     87 ± 4.1                                     9.4 ± 2.1                                     2.8 ± 1.5                                                                               18 ± 8.7                                     12 ± 5.1
  \# (×10^6^)                     238 ± 61   2.6 ± 1.5    223 ± 40      24 ± 6.4                                     6.9 ± 3.4                                     93 ± 42                                      17 ± 11                                    11 ± 7.6                                     
  **Cre/PLCγ1**^+/−^ (*n* = 8)    \%                      2 ± 0.8       87 ± 1.5                                     8.3 ± 1.5                                     2.9 ± 1.0                                                                               15 ± 5.3                                     12 ± 4.0
  \# (×10^6^)                     201 ± 88   3.6 ± 1.5    174 ± 72      17 ± 8.3                                     6.0 ± 4.0                                     118 ± 46                                     18 ± 8.6                                   13 ± 6.6                                     
  **Cre/PLCγ1**^fl/−^ (*n* = 9)   \%                      2.1 ± 1.2     95 ± 2.3[a](#tblfn1){ref-type="table-fn"}    1.5 ± 0.43[a](#tblfn1){ref-type="table-fn"}   1.2 ± 0.9[b](#tblfn2){ref-type="table-fn"}                                              3.2 ± 1.5[a](#tblfn1){ref-type="table-fn"}   5.6 ± 1.8[c](#tblfn3){ref-type="table-fn"}
  \# (×10^6^)                     172 ± 81   3.7 ± 2.8    170 ± 72      2.7 ± 1.7[c](#tblfn3){ref-type="table-fn"}   2.3 ± 2.0[d](#tblfn4){ref-type="table-fn"}    77 ± 27                                      2.7 ± 2[c](#tblfn3){ref-type="table-fn"}   4.1 ± 2.8[b](#tblfn2){ref-type="table-fn"}   

The age of the mice analyzed was between 3 and 10 wk. Data presented are average percentage (%) or absolute number (\#) of each T cell subset. The P value was calculated by comparing the percentages or absolute numbers of different T cell subsets from Cre/PLCγ1^fl/−^ mice to those from Cre/PLCγ1^+/−^ mice. There was no significant difference in the percentages and absolute numbers of different T cell subsets from PLCγ1^+/−^, PLCγ1^fl/−^, and Cre/PLCγ1^+/−^ mice.

P \< 0.0001.

P \< 0.01.

P \< 0.001.

P \< 0.05.

![**PLCγ1 deficiency impairs thymocyte maturation.** (A) PLCγ1 deficiency reduced the percentages of CD4^+^CD8^lo^ and CD4^+^CD8^−^ thymocytes. Data represent six pairs of mice. (B) PLCγ1 deficiency reduced Th-POK expression in CD4^+^CD8^lo^CD69^+^ and CD4^+^CD8^−^CD69^+^ thymocytes. Data represent two independent experiments on four Cre/YFP/PLCγ1^fl/−^ and four Cre/YFP/PLCγ1^+/−^ mice. (C) PLCγ1 deficiency reduced CD3, CD5, and CD69 expression levels on DP and SP thymocytes. Data represent three pairs of mice. (D) PLCγ1 deficiency blocks positive selection. CD4/CD8 expression profiles on total or T3-70^hi^ thymocytes from female Cre/PLCγ1^+/−^/HY and Cre/PLCγ1^fl/−^/HY mice. Data represent three pairs of mice. (E) PLCγ1 deficiency impairs negative selection. CD4/CD8 expression profiles on total or T3-70^hi^ thymocytes from male Cre/PLCγ1^+/−^/HY and Cre/PLCγ1^fl/−^/HY mice. Data represent five Cre/PLCγ1^+/−^/HY and six Cre/PLCγ1^fl/−^/HY mice.](JEM_20090880R_LW_Fig1){#fig1}

As PLCγ1 deficiency resulted in reduction of SP thymocytes, we further examined the role of PLCγ1 in thymic positive and negative selection using HY TCR transgenic mice. Each experimental mouse carried a single copy of the HY transgene. Positive selection in female Cre/PLCγ1^+/−^/HY mice resulted in high CD8SP thymocyte percentages in total (20 ± 8.2%) and T3-70^hi^ (54 ± 12%) cells ([Fig. 1 D](#fig1){ref-type="fig"}). In contrast, female Cre/PLCγ1^fl/−^/HY mice displayed a significant reduction in CD8SP thymocyte percentages in total (2.8 ± 0.66%, P = 0.02) and T3-70^hi^ (19 ± 9.0%, P = 0.01) cells. Therefore, PLCγ1 deficiency blocks positive selection. In male Cre/PLCγ1^+/−^/HY mice, negative selection significantly reduced thymic cellularity (3.8 ± 2.0 × 10^6^) and DP thymocyte percentages within total (6.3 ± 4.0%) and T3-70^hi^ (2.3 ± 1.3%) cells, with an increase in DN thymocyte percentages within total (79 ± 4.0%) and T3-70^hi^ (85 ± 6.2%) cells ([Fig. 1 E](#fig1){ref-type="fig"}). In comparison, male Cre/PLCγ1^fl/−^/HY mice had a markedly increased thymic cellularity (11 ± 4.6 × 10^6^, P = 0.01) and DP thymocyte percentages within total (42 ± 11%, P \< 0.001) and T3-70^hi^ (15 ± 7.7%, P \< 0.01) cells, with a reduction in DN thymocyte percentages within total (45 ± 9.8%, P \< 0.001) and T3-70^hi^ (68 ± 9.4%, P \< 0.01) cells ([Fig. 1 E](#fig1){ref-type="fig"}). In addition, the CD8SP cells in the T3-70^hi^ population was increased in male Cre/PLCγ1^fl/−^/HY mice (14 ± 2.6%) compared with male Cre/PLCγ1^+/−^/HY mice (8.7 ± 3.4%, P = 0.01; [Fig. 1 E](#fig1){ref-type="fig"}). These data indicated a failure of negative selection and possible conversion to positive selection in the absence of PLCγ1.

PLCγ1 deficiency results in peripheral T cell lymphopenia
---------------------------------------------------------

Cre/PLCγ1^fl/−^ mice had substantial reduction in peripheral T cells ([Fig. 2 A](#fig2){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). YFP^+^ percentage was also substantially reduced in T cells from Cre/YFP/PLCγ1^fl/−^ (CD4^+^: 57 ± 5.1%; CD8^+^: 78 ± 9.2%) relative to Cre/YFP/PLCγ1^+/−^ mice (CD4^+^: 97 ± 1.3%, P \< 0.001; CD8^+^: 98 ± 1.1%, P \< 0.001; [Fig. 2 B](#fig2){ref-type="fig"}), suggesting that PLCγ1 deficiency caused T cell incompetence. This possibility was supported by competitive BM transplantation experiments. When cotransplanted with WT BM cells, Cre/YFP/PLCγ1^fl/−^ BM cells, indicated by YFP expression, contributed significantly less to T cells than Cre/YFP/PLCγ1^+/−^ BM cells, with peripheral T cells more severely affected than thymocytes (Table S1). Together, these data indicated that PLCγ1-deficient thymocytes and peripheral T cells are less competent compared with PLCγ1-sufficient T cells.

![**PLCγ1 deficiency results in T cell lymphopenia.** (A) CD4/CD8 expression profiles on spleen and lymph node T cells from Cre/PLCγ1^+/−^ and Cre/PLCγ1^fl/−^ mice. Data represent six pairs of mice. (B) Percentages of YFP^+^ cells in splenic CD4^+^ and CD8^+^ populations from Cre/YFP/PLCγ1^+/−^ and Cre/YFP/PLCγ1^fl/−^ mice. Data represent five pairs of mice. (C) PLCγ1-deficient peripheral T cells displayed higher rates of BrdU incorporation. Data represent three pairs of mice. (D) PLCγ1-deficient T cells showed increased Fas expression. Splenocytes from Cre/YFP/PLCγ1^+/−^ (thin line) or Cre/YFP/PLCγ1^fl/−^ (thick line) mice were examined for Fas expression. Dashed lines represent isotype control. Data represent four pairs of mice. (E) PLCγ1-deficient T cells are more susceptible to AICD. 7-AAD^+^ cells are examined in CD4^+^YFP^+^ populations. Each data point is the mean of data derived from three Cre/YFP/PLCγ1^+/−^ or five Cre/YFP/PLCγ1^fl/−^ mice. \*, P \< 0.01.](JEM_20090880_GS_Fig2){#fig2}

To examine the mechanism of T cell lymphopenia, we performed TUNEL and BrdU incorporation assays. T cells from Cre/PLCγ1^fl/−^ and Cre/PLCγ1^+/−^ mice showed comparable levels of TUNEL^+^ cells (unpublished data). Compared with Cre/PLCγ1^+/−^ mice, Cre/PLCγ1^fl/−^ mice contained higher percentages of BrdU^+^ cells in SP thymocytes and splenic T cells ([Fig. 2 C](#fig2){ref-type="fig"} and not depicted), which could be caused by increased cell proliferation and/or apoptosis. Further examination showed that Fas expression was increased on T cells from Cre/YFP/PLCγ1^fl/−^ relative to Cre/YFP/PLCγ1^+/−^ mice ([Fig. 2 D](#fig2){ref-type="fig"}), whereas FasL expression was comparable (not depicted). In addition, reactivation resulted in significantly higher cell death in CD4^+^ T cells from Cre/YFP/PLCγ1^fl/−^ mice compared with Cre/YFP/PLCγ1^+/−^ mice ([Fig. 2 E](#fig2){ref-type="fig"}), suggesting that PLCγ1-deficient T cells are more susceptible to activation-induced cell death (AICD), which is consistent with increased levels of Fas expression. Thus, increased AICD may contribute to T cell lymphopenia in PLCγ1-deficient mice.

PLCγ1 is essential for TCR-mediated proliferation and cytokine production
-------------------------------------------------------------------------

T cells from Cre/YFP/PLCγ1^fl/−^ mice exhibited dramatic reduction of proliferation in response to stimulation with anti-CD3, anti-CD3/anti-CD28, or anti-CD3/IL-2 compared with those from Cre/YFP/PLCγ1^+/−^ mice, and this reduction was largely restored by PMA/ionomycin stimulation ([Fig. 3 A](#fig3){ref-type="fig"}). Therefore, PLCγ1 is critical for TCR-mediated proliferation. In addition, compared with those from Cre/YFP/PLCγ1^+/−^ mice, T cells from Cre/YFP/PLCγ1^fl/−^ mice (*n* = 3) displayed significant reduction in anti-CD3/anti-CD28--induced IL-2 production by CD4^+^ (Cre/YFP/PLCγ1^+/−^: mean fluorescence intensity (MFI) = 1741 ± 80; Cre/YFP/PLCγ1^fl/−^: MFI = 899 ± 98, P \< 0.01) and CD8^+^ (Cre/YFP/PLCγ1^+/−^: MFI = 1685 ± 69; Cre/YFP/PLCγ1^fl/−^: MFI = 1102 ± 119, P \< 0.01) T cells ([Fig. 3 B](#fig3){ref-type="fig"}). The percentages of IFN-γ^+^ T cells from Cre/YFP/PLCγ1^fl/−^ mice after anti-CD3/anti-CD28 stimulation were also reduced, but not significant in either CD4^+^ (Cre/YFP/PLCγ1^+/−^: 25 ± 16%; Cre/YFP/PLCγ1^fl/−^: 15 ± 2.5%, P = 0.3) or CD8^+^ (Cre/YFP/PLCγ1^+/−^: 54 ± 6.0%; Cre/YFP/PLCγ1^fl/−^: 38 ± 15%, P = 0.1) T cells ([Fig. 3 B](#fig3){ref-type="fig"}). Without differentiation, IL-4 was not detected in CD4^+^ T cells, regardless of PLCγ1 expression (unpublished data). Therefore, whereas PLCγ1 deficiency significantly reduces IL-2 production, it only slightly reduces IFN-γ production by T cells.

![**The effect of PLCγ1 deficiency on proliferation, cytokine production, and TCR signaling.** (A) PLCγ1 deficiency impairs TCR-mediated proliferation. (B) The effect of PLCγ1 deficiency on IL-2 and IFN-γ production. (C) PLCγ1 deficiency impairs TCR-mediated Ca^2+^ mobilization in both SP thymocytes and splenic T cells. (D) PLCγ1 deficiency impairs TCR-mediated ERK and JNK activation. (E) PLCγ1 deficiency impairs TCR-mediated AP-1, NFAT, and NF-κB activation. All data shown are representative of three independent experiments. The numbers shown in B represent IFN-γ^+^ T cells from one pair of mice after anti-CD3/anti-CD28 stimulation.](JEM_20090880_GS_Fig3){#fig3}

PLCγ1 deficiency impairs TCR signaling
--------------------------------------

We further examined the effect of PLCγ1 deficiency on TCR-mediated signaling. Compared with Cre/PLCγ1^+/−^ mice, T cells from Cre/PLCγ1^fl/−^ mice displayed markedly reduced TCR-induced Ca^2+^ flux, but higher basal Ca^2+^ level in the CD4SP thymocytes ([Fig. 3 C](#fig3){ref-type="fig"}). Although basal level activities of ERK and JNK were high in T cells from Cre/PLCγ1^fl/−^ mice, TCR-mediated activation of these kinases was reduced compared with those from Cre/PLCγ1^+/−^ mice ([Fig. 3 D](#fig3){ref-type="fig"}). Moreover, regardless of CD28 stimulation, TCR-induced activation of transcription factors NFAT, NF-κB, and AP-1 was severely impaired in T cells from Cre/PLCγ1^fl/−^ relative to Cre/PLCγ1^+/−^ mice ([Fig. 3 E](#fig3){ref-type="fig"}). Collectively, these data demonstrate that PLCγ1 plays a central role in TCR-mediated activation of multiple signaling pathways.

PLCγ1-deficient mice develop inflammatory/autoimmune disease
------------------------------------------------------------

From 2--3 wk of age, most Cre/PLCγ1^fl/−^ mice were apparently runt ([Fig. 4 A](#fig4){ref-type="fig"}), with reduced weight in both male and female mice compared with littermate control mice ([Fig. 4 B](#fig4){ref-type="fig"} and not depicted). One third of Cre/PLCγ1^fl/−^ mice developed variable visible symptoms, including alopecia, dermatitis, and rectal prolapse (symptomatic mice), with the latter two symptoms more frequent. Whereas none of the littermate control mice exhibited significant histological abnormalities, a majority of symptomatic Cre/PLCγ1^fl/−^ mice showed infiltration of mononuclear cells into variable tissues, particularly skin and ear ([Fig. 4 C](#fig4){ref-type="fig"}). Although Cre/PLCγ1^fl/−^ mice were severely T cell lymphopenic, the skin and ear were infiltrated by CD3^+^ T cells, which was not observed in the corresponding areas of the littermate control mice ([Fig. 4 D](#fig4){ref-type="fig"}). Serum anti--double-stranded DNA antibodies were significantly higher in symptomatic Cre/PLCγ1^fl/−^ relative to nonsymptomatic Cre/PLCγ1^fl/−^ or control mice ([Fig. 4 E](#fig4){ref-type="fig"}). Nevertheless, serum antinuclear antibodies were comparable ([Fig. 4 E](#fig4){ref-type="fig"}). The experimental mice analyzed were backcrossed with C57BL/6 mice for three generations. We have since determined that Cre/PLCγ1^fl/−^ mice backcrossed with C57BL/6 mice for eight generations displayed the same phenotypes (unpublished data). Although we cannot entirely exclude background gene effects, we can conclude that the inflammatory/autoimmune syndrome in Cre/PLCγ1^fl/−^ mice is attributable to PLCγ1 deficiency.

![**Cre/PLCγ1^fl/^**^−^**mice develop inflammatory/autoimmune disease.** (A) Cre/PLCγ1^fl/−^ mice were smaller than littermate control mice. A pair of 6-wk-old littermates is shown. (B) PLCγ1 deficiency reduced weight gain in Cre/PLCγ1^fl/−^ mice. Each point represents the mean weight of 7 to 14 female mice. \*: P \< 0.05. (C) Infiltration of inflammatory cells in the skin and ear (H&E, x200) of Cre/PLCγ1^fl/−^ mice. Bar, 100 µm. (D) Infiltration of CD3^+^ T cells in the skin and ear (x200) of Cre/PLCγ1^fl/−^ mice. The slides were analyzed by immunohistochemistry and examined by Nikon Eclipse E600. Bar, 100 µm. (E) Levels of α-double-stranded DNA antibodies and antinuclear antibodies in the serum of symptomatic Cre/PLCγ1^fl/−^ mice compared with the indicated control mice.](JEM_20090880_RGB_Fig4){#fig4}

PLCγ1 deficiency impairs T reg cell development and function
------------------------------------------------------------

T cells in Cre/YFP/PLCγ1^fl/−^ mice showed activated phenotype, including larger cell sizes, decreased CD62L, and increased CD44 expression compared with those in Cre/YFP/PLCγ1^+/−^ mice ([Fig. 5 A](#fig5){ref-type="fig"}). T cell lymphopenia and the activated phenotype of PLCγ1-deficient T cells were largely corrected in mice receiving Cre/YFP/PLCγ1^fl/−^ and WT BM cells (Fig. S3). Thus, T cell lymphopenia may contribute to the activated T cell phenotype in PLCγ1-deficient mice. Alternatively, given that the symptoms of Cre/PLCγ1^fl/−^ mice are reminiscent of mice deficient in FoxP3^+^ T reg cells ([@bib6]; [@bib9]; [@bib11]), the autoimmune phenotype may be consequent to impaired T reg cells. The percentage and absolute number of T reg cells were substantially reduced in thymus in Cre/PLCγ1^fl/−^ relative to Cre/PLCγ1^+/−^ mice ([Fig. 5, B and C](#fig5){ref-type="fig"}). Although T reg cell percentage was reduced in lymphocytes in the spleen and lymph nodes of Cre/PLCγ1^fl/−^ relative to Cre/PLCγ1^+/−^ mice, it was substantially increased in CD4^+^ T cells ([Fig. 5 B](#fig5){ref-type="fig"}). Nevertheless, T reg cell number was dramatically reduced in the spleen from Cre/PLCγ1^fl/−^ relative to Cre/PLCγ1^+/−^ mice ([Fig. 5 C](#fig5){ref-type="fig"}). We performed suppression assays to determine T reg cell suppressive functions. Compared with those from Cre/YFP/PLCγ1^+/−^ mice, YFP^+^ T reg cells from Cre/YFP/PLCγ1^fl/−^ mice had reduced ability to suppress naive T cell proliferation ([Fig. 5 D](#fig5){ref-type="fig"}). Furthermore, we transferred purified WT T reg cells into 10 10-d-old Cre/YFP/PLCγ1^fl/−^ mice to determine whether impaired T reg cells contributed to the disease phenotype in PLCγ1-deficient mice. None of them developed symptoms such as alopecia, dermatitis, and rectal prolapse. These mice gained weight at a rate similar to WT mice ([Fig. 5 E](#fig5){ref-type="fig"}). WT T reg cells also partially corrected the activated phenotype of Cre/YFP/PLCγ1^fl/−^ T cells, as CD62L expression was increased ([Fig. 5 F](#fig5){ref-type="fig"}). Collectively, PLCγ1 deficiency impaired T reg cell development and functions, which may contribute to the inflammatory/autoimmune disease in the PLCγ1-deficient mice.

![**PLCγ1 deficiency impairs T reg cell development and function.** (A) PLCγ1-deficient T cells display activated phenotype. Data are representative of four pairs of mice. (B) Percentages of FoxP3^+^ T reg cells in total and CD4-gated lymphocytes in the thymus, spleen, and lymph node cells. Data represent five pairs of mice. (C) CD4^+^FoxP3^+^ cell numbers were reduced in thymus and spleen of Cre/PLCγ1^fl/−^ mice. Data represent five pairs of mice. (D) PLCγ1 deficiency impairs the inhibitory functions of T reg cells. Error bars represent the standard deviation of triplicate measurements of each data point. \*: P \< 0.05, \*\*: P \< 0.01. Data are representative of two independent experiments. (E) WT T reg cell reconstitution restores normal weight gain in Cre/PLCγ1^fl/−^ mice. Each point represents the mean weight of 7 to 14 female Cre/PLCγ1^+/−^ mice or 6 female Cre/PLCγ1^fl/−^ mice that received WT T reg cells. (F) WT T reg cell reconstitution restores high CD62L expression on PLCγ1-deficient T cells. Data represent three independent experiments.](JEM_20090880R_GS_Fig5){#fig5}

The development of inflammatory/autoimmunity in Cre/PLCγ1^fl/−^ mice could be attributed to a couple of possibilities. First, impairment of thymic negative selection allows autoreactive thymocytes that would normally be eliminated, to survive and mature into periphery and become pathogenic T cells. To determine whether PLCγ1 deficiency altered the T cell TCR repertoire, we performed spectratyping analysis of 18 Vβ subfamilies ([@bib16]) on cDNA isolated from Cre/YFP/PLCγ1^fl/−^ and Cre/YFP/PLCγ1^+/−^ thymocytes. The CD4SPYFP^+^ cells from either of the mice showed a Gaussian distribution of CDR3 length commensurate with normal selection (unpublished data). Interestingly, the CDR3 length profiles of CD8SPYFP^+^ cells from Cre/YFP/PLCγ1^fl/−^ mice differed from the Gaussian profile seen in the control PLCγ1^+/−^ mice for several subfamilies examined (unpublished data). Thus, while PLCγ1 deficiency affects the naive CD8 repertoire, the effect, if any, on naive CD4 repertoire involves more subtle changes that do not alter the overall distribution of CDR3 lengths. Second, impaired function of T regs in Cre/PLCγ1^fl/−^ mice also contribute to the autoimmune phenotype, as shown in mice deficient in T reg cells ([@bib6]; [@bib9]; [@bib11]; [@bib15]). Consistently, knock-in mice homozygous for a single tyrosine mutation in LAT (Y136F), which impairs PLCγ1 activation, develop signs of autoimmune disease ([@bib1]; [@bib23]), which is attributed to impaired negative selection and T reg cells ([@bib24]; [@bib12]). Despite the similarities between LAT (Y136F) knock-in and Cre/PLCγ1^fl/−^ mice, these two mutant mice display several significant differences. First, lymphoproliferative disorder, particularly of CD4^+^ T cells in LAT (Y136F) knock-in mice was in contrast to the severe lymphopenia, particularly of CD4^+^ T cells in Cre/PLCγ1^fl/−^ mice. Second, CD4^+^ T cells from LAT (Y136F) knock-in mice exhibit substantial IL-4 production without in vitro differentiation, whereas those from Cre/PLCγ1^fl/−^ mice do not produce IL-4. Lastly, T cells derived from LAT (Y136F) knock-in mice have normal ERK activation, whereas those from Cre/PLCγ1^fl/−^ mice have markedly impaired ERK activation. These differences emphasize that Y136F mutation in LAT is not equivalent to the deletion of PLCγ1. Cre/PLCγ1^fl/−^ mice are unique in uncovering the biological function of PLCγ1 in T cells. The impaired function of PLCγ1-deficient T reg cells is likely attributed to defective TCR-mediated Ca^2+^ flux and NFAT activation, because T cells deficient for STIM1 and STIM2 also displayed impairment of T reg functions ([@bib18]). In addition, T reg function is mediated by an interaction between NFAT and FOXP3, disruption of which substantially inhibited T reg suppressive function ([@bib28]).

PLCγ1 deficiency affects the development of CD4^+^ T cells more profoundly than that of CD8^+^ T cells, resulting in lower CD4/CD8 ratio in both the thymus and periphery of Cre/PLCγ1^fl/−^ mice relative to controls, reminiscent of mice lacking both Itk and Rlk ([@bib3]). Nevertheless, the CD8SP thymocytes in PLCγ-deficient mice appeared not to be the innate type CD8^+^ T cells (CD122^+^) developed in the Itk and Rlk double-deficient mice, as they were CD122^−^ (unpublished data). In addition, percentages of CD4^+^ T cells were not reduced in the Itk and Rlk double-deficient mice ([@bib3]). It is possible that CD4^+^ and CD8^+^ cells display a different degree of PLCγ1 dependence. It is proposed in the kinetic signaling model that proper TCR signaling at the thymic DP stage results in positive selection and a reduction in the intensity of CD8, leading to an appearance of the bipotent CD4^+^CD8^lo^ thymocytes ([@bib22]). Extended TCR signaling in the CD4^+^CD8^lo^ thymocytes, a sign of MHC class II recognition, results in Th-POK expression, which in turn leads to differentiation into CD4 lineage. In contrast, attenuated TCR signaling as a result of CD8 expression loss, denoting MHC class I recognition, leads to CD8 T cell development. Our data showed that PLCγ1 is required for CD4^+^CD8^lo^ thymocyte development as well as Th-POK expression in CD4^+^CD8^lo^ and CD4^+^CD8^−^ thymocytes. Consequently, PLCγ1 deficiency impairs both CD4 and CD8 development with CD4 lineage more affected.

The reason for elevated basal calcium and MAPK activity is not clear. PLCγ1-deficient T cells had activated phenotype, which may account for elevated basal Ca^2+^ and MAPK activity. Our study showed that both lymphopenia and impaired T reg cells may contribute to the activated T cell phenotype. In addition, Cbl-b up-regulation was severely impaired in PLCγ1-deficient T cells (unpublished data). Several studies have shown that Cbl-b plays an important role in down-regulating TCR expression and peripheral T cell activation ([@bib2]; [@bib4]; [@bib17]). In addition, a previous study showed that CD5 deficiency enhances PLCγ1 activation ([@bib27]). Thus, impaired CD5 up-regulation in PLCγ1-deficient T cells could enhance the activation of PLCγ2, which is involved in TCR signal transduction. It is possible that enhanced basal level Ca^2+^ and Erk activation may be the consequence of peripheral lymphopenia, impaired T reg cell number/functions, and defective CD5 and Cbl up-regulation.

In conclusion, we observed that PLCγ1 deficiency severely impairs TCR-induced activation of multiple signaling molecules and transcription factors, and unveiled a crucial role of PLCγ1 in T cell development, activation, and tolerance.

MATERIALS AND METHODS
=====================

### Mice.

HY TCR and CD4Cre transgenic mice were purchased from Taconic. PLCγ1^+/−^ and Rosa-26-YFP mice were generously provided by G. Carpenter (Vanderbilt University, Nashville, TN; [@bib10]) and F. Costantini (Columbia University, New York, NY; [@bib25]), respectively. PLCγ1-deficient and control mice were originally on a mixed 129xC57BL/6 background. The experimental mice were backcrossed onto the C57BL/6 background for three generations. Mice analyzed were between 6 and 12 wk old unless otherwise stated. Mice were maintained in the Biological Resource Center at the Medical College of Wisconsin (MCW). All animal protocols were approved by the MCW Institutional Animal Care and Use Committee.

### Cell proliferation and intracellular cytokine analysis.

Splenocytes were labeled with PKH Fluorescent Cell Linker Dye (PKH26; Sigma-Aldrich) according to the manufacturer's recommendation and stimulated for 72 h before analysis for cell proliferation. For intracellular cytokine staining, total splenocytes (1.5 × 10^6^/ml) were stimulated for 36 h, followed by 6 h of monensin treatment. The cells were then harvested and stained with α-CD4 and α-CD8 antibodies, followed by intracellular staining for IL-2, IL-4, and IFN-γ according to manufacture's recommendation (eBioscience).

### Real-time PCR analysis of Th-POK expression.

CD4^+^CD8^lo^CD69^+^YFP^+^ and CD4^+^CD8^−^CD69^+^YFP^+^ thymocytes were purified from Cre/YFP/PLCγ1^fl/−^ and Cre/YFP/PLCγ1^+/−^ mice and total RNA was extracted. Th-POK expression was examined by real-time PCR as previously described ([@bib8]).

### Calcium flux analysis.

Thymocytes or splenocytes (2 × 10^6^) were loaded with indo-1^AM^ in 1 ml PBS (2% FBS + 10 µg/ml indo-1^AM^) for 30 min. The cells were then incubated with FITC-α-CD4 + PE-α-CD8 + biotin-α-CD3 (20 µg/ml) in 200 µl PBS (2% FBS) for 15 min. After washing, the cells were resuspended in 1 ml medium and run on a LSRII (BD). Baseline data were collected for 30 s, streptavidin (Thermo Fisher Scientific) was added to a final concentration of 8 µg/ml to cross-link the TCR, and data were then collected by the LSRII for another 9 min.

### BrdU incorporation assay.

Mice were injected i.p. with 1 mg BrdU in 200 µl PBS at 12-h intervals for 5 d. Splenocytes were then prepared for analysis. The BrdU staining was performed according to the manufacturer's instructions (BD).

### AICD.

3 × 10^6^ purified CD4^+^ peripheral T cells were stimulated with plate-bound α-CD3 (5 µg/ml α-CD3 coated) in 1 ml of T cell medium for 2 d, and the cells were collected and cultured at 3 × 10^6^ cells/ml in T cell medium in the presence of 30 U/ml IL-2 for an additional day. The cells were then collected and further cultured at 10^6^ cells/ml in media alone or stimulated with plate-bound α-CD3 (0.01, 0.1, 1, and 5 µg/ml α-CD3 coated) for 1 d. 24 h later, the cells were collected and stained for CD4 and CD8 and resuspended in PBS with 7-AAD (1 µg/ml) and analyzed by FACS.

### T reg suppression assay.

Naive CD4^+^ T cells (CD4^+^CD25^−^, 2 × 10^4^) pooled from spleen and lymph node were stimulated with 2 µg/ml α-CD3 in the presence of 8 × 10^4^ irradiated (3000Rad) splenocytes in 200 µl culture medium in a round-bottomed plate. Indicated portions of FACS-sorted CD4^+^CD25^+^YFP^+^ T reg cells from the spleen and lymph nodes of Cre/YFP/PLCγ1^+/−^ or Cre/YFP/PLCγ1^fl/−^ mice were added at the beginning of the culture. After 48 h of culture, the cells were pulsed and harvested as previously described ([@bib29]).

### T reg transfer experiment.

WT T reg cells were sorted based on CD4 and GFP expression from *Foxp3*^EGFP^ mice, in which a bicistronic locus encoding both Foxp3 and EGFP was under the control of the *Foxp3* promoter ([@bib7]). Each 10-d-old Cre/YFP/PLCγ1^fl/−^ pup received 5 × 10^5^ purified WT T reg cells through i.p. injection and were weighed and observed for 3 mo afterward.

### Statistical analysis.

All P values were calculated according to two-tailed Student's *t* test analysis. Datasets are presented as mean ± SD.

### Online supplemental material.

Fig. S1 describes strategies for T-lineage--specific deletion of *PLCγ1*. Fig. S2 shows PLCγ1 protein levels in T cells derived from Cre/PLCγ1^fl/−^ and Cre/YFP/PLCγ1^fl/−^ and control mice. Fig. S3 demonstrates that the activated phenotype is not an intrinsic phenotype of the PLCγ1-deficient T cells. Table S1 demonstrates that PLCγ1-deficient T cells are less competitive than WT T cells in the periphery. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20090880/DC1>.
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